• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»spine surgery devices

Intrinsic Therapeutics introduces Barricaid Narrow Anchor as surgeons seek better reherniation prevention tools

By Pallavi Madhiraju on March 5, 2026   Medical Devices & Diagnostics  

Intrinsic Therapeutics introduces Barricaid Narrow Anchor as surgeons seek better reherniation prevention tools

Intrinsic Therapeutics launches the Barricaid Narrow Anchor for lumbar discectomy patients. Explore what the smaller implant could change in spine surgery.

Life Spine strengthens ProLift’s long-term viability as MRI compatibility becomes a procurement baseline

By Pallavi Madhiraju on February 20, 2026   Medical Devices & Diagnostics  

Life Spine strengthens ProLift’s long-term viability as MRI compatibility becomes a procurement baseline

Life Spine confirms MR Conditional status for ProLift. Find out why MRI compatibility now defines spine implant viability rather than differentiation.

Recent Posts

  • Can Orum Therapeutics crack one of AML’s hardest problems with ORM-1153? AACR 2026 data spark fresh attention
  • How NEU-002 could reshape Onchilles Pharma’s systemic solid tumor strategy after AACR 2026
  • Is CD39 finally ready for a breakout moment in lung cancer? Innate Pharma tests the thesis
  • Can bispecific ADCs give NEOK Bio a more credible route into solid tumor drug development?
  • AACR 2026: SingleCell Biotechnology targets oncology’s blind spot with functional single-cell profiling
  • Can Zai Lab’s ZL-1503 turn dual-pathway itch control into a real atopic dermatitis advantage?
  • IntoDNA unveils sSTRIDE-NER and sSTRIDE-PARP1 at AACR 2026, can functional DNA repair assays reshape precision oncology?
  • Soley Therapeutics shows early tumor selectivity for STX-6398, but can CKAP2 modulation scale?
  • Akamis Bio AACR 2026 update: what early NG-350A data could mean for organ preservation
  • AACR 2026: SAGA Diagnostics pushes Pathlight MRD deeper into metastatic breast and ovarian cancer
  • Agenus AACR 2026 data show immune reprogramming signal in PD-1 refractory gastroesophageal cancer
  • AACR 2026: Can Zai Lab’s zocilurtatug pelitecan change the treatment picture for small cell lung cancer brain metastases?
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes